Actuate Therapeutics Files Q1 2025 10-Q
Ticker: ACTU · Form: 10-Q · Filed: May 15, 2025 · CIK: 1652935
| Field | Detail |
|---|---|
| Company | Actuate Therapeutics, Inc. (ACTU) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Actuate Therapeutics dropped its Q1 2025 10-Q. Check financials.
AI Summary
Actuate Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2025. The company, formerly known as Apotheca Therapeutics, Inc., is based in Fort Worth, Texas, and operates in the pharmaceutical preparations sector. The filing details financial information for the first quarter of 2025, comparing it to the same period in 2024 and the fiscal year-end of 2024.
Why It Matters
This filing provides investors with an update on Actuate Therapeutics' financial performance and position as of March 31, 2025, crucial for understanding the company's ongoing operations and potential.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Actuate Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are not detailed in this summary but are typical for the sector.
Key Numbers
- Q1 2025 — Reporting Period (Financials for the first quarter of 2025 are detailed.)
- March 31, 2025 — As of Date (The report reflects the company's status on this date.)
- 2024-12-31 — Fiscal Year End (Comparison point for financial data.)
Key Players & Entities
- ACTUATE THERAPEUTICS, INC. (company) — Filer
- Apotheca Therapeutics, Inc. (company) — Former company name
- Fort Worth, TX (location) — Business Address
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-42139 (sec_file_number) — SEC File Number
FAQ
What is the primary business of Actuate Therapeutics, Inc.?
Actuate Therapeutics, Inc. operates in the Pharmaceutical Preparations sector, with the Standard Industrial Classification code 2834.
When was Actuate Therapeutics, Inc. formerly known as?
Actuate Therapeutics, Inc. was formerly known as Apotheca Therapeutics, Inc., with a name change date of September 11, 2015.
What is the business address of Actuate Therapeutics, Inc.?
The business address for Actuate Therapeutics, Inc. is 1751 River Run, Suite 400, Fort Worth, TX 76107.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
What is the SEC file number for Actuate Therapeutics, Inc.?
The SEC file number for Actuate Therapeutics, Inc. is 001-42139.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).